Supplemental material
Expert Review of Clinical Pharmacology
Volume 15, 2022 - Issue 11
Original Research
Interstitial lung disease associated with anti-HER2 anti-body drug conjugates: results from clinical trials and the WHO's pharmacovigilance database
Zhuo Maa Department of Pharmacy, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
https://orcid.org/0000-0002-3424-0139View further author information
https://orcid.org/0000-0002-3424-0139View further author information, Yi Zhanga Department of Pharmacy, Beijing Chaoyang Hospital, Capital Medical University, Beijing, Chinahttps://orcid.org/0000-0001-8806-847XView further author information
https://orcid.org/0000-0001-8806-847XView further author information, , Lin Fengc Department of Clinical Epidemiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing Institute of Respiratory Medicine, Beijing, Chinahttps://orcid.org/0000-0002-6134-4937View further author information
https://orcid.org/0000-0002-6134-4937View further author information, & Zhuoling Ana Department of Pharmacy, Beijing Chaoyang Hospital, Capital Medical University, Beijing, ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-7996-5002View further author information
https://orcid.org/0000-0002-7996-5002View further author information